However, the presence of CEA > 5.0 ng/mL at the initial RECIST evaluation indicates that the cases with CEA > 5.0 ng/mL did not show the marked shrinkage necessary to implement CS, while those with CEA ≤ 5.0 ng/mL had tumor progression. Here, CEACAM5 is linked to neoplasm.